z-logo
open-access-imgOpen Access
Diagnostics of early forms of syphilis by the chemiluminescence immunoassay method
Author(s) -
Н В Фриго,
T YE MANUKIAN,
С В Ротанов,
Г Л Катунин
Publication year - 2013
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv604
Subject(s) - syphilis , medicine , immunoassay , syphilis serodiagnosis , latent syphilis , serology , chemiluminescent immunoassay , chemiluminescence , immunology , antibody , chromatography , human immunodeficiency virus (hiv) , chemistry
Goal. Assessment of the diagnostic efficacy of the chemiluminescence immunoassay (CLIA) method for early forms of acquired syphilis. Materials and methods. The authors examined 237 blood serum samples taken from patients suffering from primary (49), secondary (116) and latent early (72) syphilis as well as from 61 healthy blood donors and 20 persons with false-positive results of serological tests for syphilis. Blood serum samples were tested with the use of CLIA, EIA, passive hemagglutination test, immunofluorescence test and microprecipitation test methods. Results. The authors established that the CLIA method used for diagnostics of early forms of acquired syphilis (when the IMMULITE® 2000 Syphilis Screen test system is used) is characterized by high sensitivity (99.6%), specificity (95.1%), diagnostic efficacy (98.3%), predictive value of positive (95.1%) and negative (98.3%) results, which is sufficient for recommending this method as the screening method for diagnostics of syphilis to be used in large diagnostic centers. The CLIA method may also be used to confirm the diagnosis of syphilis. Conclusion. Based on these results, the authors developed a reverse algorithm for diagnostics of early forms of acquired syphilis beginning with the use of the CLIA method with further use of the nontreponemal method (microprecipitation reaction or other nontreponemal method).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here